Characterization of mexican generic market
- At: 2004 FIP Congress in New Orleans (USA)
- Type: Poster
- By: KRAVZOV-JINICH, Jaime (UAM-Xochimilco, Biological System, México Df, Mexico)
- Co-author(s): Altagracia-Martínez (UAM-Xochimilco, MéXICO DF, Mexico)
Rosales-Romero (UAM-Xochimilco, MéXICO DF, Mexico)
Jung-Cook (UNAM, Mexico)
In Latin America, pharmaceutical patenting remains a relatively new concept. As member of NAFTA (1994), Mexico is committed to a high level of intelellectual property protection, closely resembling the USA and Canada in this respect.
This study examined the current drug markets, highlighting any weaknessess, and suggested policy options that.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.